SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 2/28/18 Pacira BioSciences, Inc. 10-K 12/31/17 87:10M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.15M 2: EX-10.14 Material Contract HTML 122K 3: EX-21.1 Subsidiaries List HTML 21K 4: EX-23.1 Consent of Experts or Counsel HTML 24K 5: EX-23.2 Consent of Experts or Counsel HTML 24K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 29K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 29K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 23K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 23K 16: R1 Document and Entity Information HTML 50K 17: R2 Consolidated Balance Sheets HTML 108K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 43K 19: R4 Consolidated Statements of Operations HTML 91K 20: R5 Consolidated Statements of Comprehensive Income HTML 36K (Loss) 21: R6 Consolidated Statements of Stockholders' Equity HTML 96K 22: R7 Consolidated Statements of Cash Flows HTML 119K 23: R8 Description of Business HTML 28K 24: R9 Summary of Significant Accounting Policies HTML 120K 25: R10 Recent Accounting Pronouncements HTML 43K 26: R11 Inventories HTML 33K 27: R12 Fixed Assets HTML 43K 28: R13 Goodwill and Intangible Assets HTML 41K 29: R14 Accrued Expenses HTML 35K 30: R15 Debt HTML 89K 31: R16 Financial Instruments HTML 102K 32: R17 Stockholders' Equity HTML 34K 33: R18 Stock Plans HTML 177K 34: R19 Net Income (Loss) Per Share HTML 70K 35: R20 Income Taxes HTML 111K 36: R21 Other Employee Benefits HTML 27K 37: R22 Commercial Partners and Other Agreements HTML 66K 38: R23 Related Party Transactions HTML 31K 39: R24 Commitments and Contingencies HTML 43K 40: R25 Selected Quarterly Financial Data (Unaudited) HTML 63K 41: R26 Summary of Significant Accounting Policies HTML 200K (Policies) 42: R27 Summary of Significant Accounting Policies HTML 86K (Tables) 43: R28 Inventories (Tables) HTML 33K 44: R29 Fixed Assets (Tables) HTML 37K 45: R30 Goodwill and Intangible Assets (Tables) HTML 32K 46: R31 Accrued Expenses (Tables) HTML 34K 47: R32 Debt (Tables) HTML 60K 48: R33 Financial Instruments (Tables) HTML 93K 49: R34 Stockholders' Equity (Tables) HTML 31K 50: R35 Stock Plans (Tables) HTML 138K 51: R36 Net Income (Loss) Per Share (Tables) HTML 71K 52: R37 Income Taxes (Tables) HTML 76K 53: R38 Commercial Partners and Other Agreements HTML 47K Commerical Partners and Other Agreements (Tables) 54: R39 Commitments and Contingencies (Tables) HTML 33K 55: R40 Selected Quarterly Financial Data (Unaudited) HTML 63K (Tables) 56: R41 Summary of Significant Accounting Policies HTML 26K (Details) 57: R42 Summary of Significant Accounting Policies Summary HTML 44K of Significant Accounting Policies (Details 2) 58: R43 Summary of Significant Accounting Policies HTML 37K (Details 3) 59: R44 Summary of Significant Accounting Policies HTML 37K (Details 4) 60: R45 RECENT ACCOUNTING PRONOUNCEMENTS Recent Accounting HTML 26K Pronouncements (Details) 61: R46 Inventories (Details) HTML 36K 62: R47 Fixed Assets (Details) HTML 59K 63: R48 Goodwill and Intangible Assets (Details) HTML 65K 64: R49 Goodwill and Intangible Assets Schedule of HTML 26K Intangible Assets (Details) 65: R50 Accrued Expenses (Details) HTML 35K 66: R51 Debt (Details) HTML 157K 67: R52 Debt (Details 2) HTML 40K 68: R53 Financial Instruments (Details) HTML 75K 69: R54 Financial Instruments (Details 2) HTML 60K 70: R55 Financial Instruments (Details 3) HTML 36K 71: R56 Stockholders' Equity (Details) HTML 29K 72: R57 Stockholders' Equity (Details 2) HTML 35K 73: R58 Stock Plans (Details) HTML 71K 74: R59 Stock Plans (Details 2) HTML 43K 75: R60 Stock Plans (Details 3) HTML 155K 76: R61 Net Income (Loss) Per Share (Details) HTML 58K 77: R62 Net Income (Loss) Per Share (Details 2) HTML 39K 78: R63 Income Taxes (Details) HTML 151K 79: R64 Other Employee Benefits (Details) HTML 25K 80: R65 Commercial Partners and Other Agreements (Details) HTML 120K 81: R66 Related Party Transactions (Details) HTML 43K 82: R67 Commitments and Contingencies (Details) HTML 52K 83: R68 Commitments and Contingencies (Details 2) HTML 34K 84: R69 Selected Quarterly Financial Data (Unaudited) HTML 39K (Details) 86: XML IDEA XML File -- Filing Summary XML 149K 85: EXCEL IDEA Workbook of Financial Reports XLSX 105K 10: EX-101.INS XBRL Instance -- pcrx-20171231 XML 2.70M 12: EX-101.CAL XBRL Calculations -- pcrx-20171231_cal XML 245K 13: EX-101.DEF XBRL Definitions -- pcrx-20171231_def XML 713K 14: EX-101.LAB XBRL Labels -- pcrx-20171231_lab XML 2.02M 15: EX-101.PRE XBRL Presentations -- pcrx-20171231_pre XML 1.07M 11: EX-101.SCH XBRL Schema -- pcrx-20171231 XSD 203K 87: ZIP XBRL Zipped Folder -- 0001396814-18-000009-xbrl Zip 286K
Exhibit |
(a) | designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | disclosed in this report any
change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and |
(b) | any
fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal control over financial reporting. |
Date: | ||
Chief Financial Officer (Principal Financial Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/28/18 | 8-K | ||
For Period end: | 12/31/17 | |||
List all Filings |